Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

812
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
812

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct Lp(a)-C measurements provide evidence for Apo(a) isoform-dependent cholesterol composition of Lp(a).

Journal of lipid research·2026
Same author

Analytical validation of a direct lipoprotein(a)-cholesterol assay.

Journal of lipid research·2026
Same author

Effect of weight loss through dietary interventions on cardiometabolic health in older adults.

International journal of obesity (2005)·2025
Same author

Trends in CVD Risk Factors for Youth with Incident Diabetes: SEARCH for Diabetes in Youth.

Pediatric diabetes·2025
Same author

Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity.

JAMA network open·2025
Same author

Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study.

Diabetes care·2024

Related Experiment Video

Updated: Mar 29, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K

Lipoprotein (a) measurements for clinical application.

Santica M Marcovina1, John J Albers2

  • 1Northwest Lipid Metabolism and Diabetes Research Laboratories, Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA smm@uw.edu.

Journal of Lipid Research
|December 6, 2015
PubMed
Summary

Measuring lipoprotein (a) [Lp(a)] is challenging due to the variable size of its apo(a) protein component. This size heterogeneity causes inaccurate results and hinders standardization for assessing cardiovascular disease risk.

Keywords:
analytical methodsapolipoprotein (a)assay standardizationcardiovascular disease

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

537
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.7K

Related Experiment Videos

Last Updated: Mar 29, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.9K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

537
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.7K

Area of Science:

  • Clinical Chemistry
  • Cardiovascular Diagnostics
  • Protein Biochemistry

Background:

  • Lipoprotein (a) [Lp(a)] is a significant risk factor for cardiovascular disease.
  • The apo(a) protein component of Lp(a) exhibits substantial size heterogeneity.
  • This heterogeneity complicates the development of accurate immunoassays for Lp(a) measurement.

Purpose of the Study:

  • To critically evaluate challenges in measuring Lp(a) concentrations.
  • To assess the impact of measurement variability on clinical interpretation.
  • To identify obstacles hindering the standardization of Lp(a) assays.

Main Methods:

  • Review of existing literature on Lp(a) measurement techniques.
  • Analysis of factors contributing to apo(a) size-dependent assay inaccuracy.
  • Evaluation of current validation practices and reporting of Lp(a) results.

Main Results:

  • Apo(a) size variability between and within individuals leads to antigenic determinant differences.
  • This variability causes size-dependent inaccuracies in current Lp(a) immunoassays.
  • Lack of rigorous validation and common reporting units impede result harmonization.

Conclusions:

  • Standardization of Lp(a) measurements is essential for accurate clinical risk assessment.
  • Overcoming apo(a) size heterogeneity is crucial for developing reliable Lp(a) assays.
  • Harmonized Lp(a) results are needed to establish common clinical cut points for intervention.